Scholarlink

Background <p>Predicting mortality and major adverse cardiovascular events (MACE) in Type 2 diabetes mellitus (T2DM) is important, but no routinely recommended risk score exists. The HANBAH Score is a recently established risk score for mortality prediction in acute heart failure. This study aimed to investigate the relationship between the HANBAH Score and mortality and MACE in T2DM patients.</p> Methods <p>This study was retrospective, and patients who applied to the outpatient clinic diagnosed with T2DM were included. The patients’ HANBAH Score was calculated. The relationship between the HANBAH score and mortality and MACE was examined.</p> Results <p>7611 T2DM patients were included in this study. The mean age of the patients was 59.1 ± 12.8 years, and 3187 (41.9%) were male. The mortality rate was 1% (76 patients), and the MACE rate was 5.8% (438 patients). The mean follow-up time was 604 days. HANBAH Score was an independent predictor of mortality (HR: 2.260, 95%CI:1.738–2.939, <i>p</i> &lt; 0.001) and MACE (HR: 1.238, 95%CI:1.094-1.400, <i>p</i> &lt; 0.001). ROC curve analysis showed that HANBAH Score highly predicted mortality (AUC: 0.846, 95%CI: 0.794–0.898, <i>p</i> &lt; 0.001).</p> Conclusions <p>This study showed that the HANBAH Score is a predictor of MACE and mortality in patients with T2DM.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prognostic significance of HANBAH score in evaluating mortality and major adverse cardiovascular events in patients with diabetes mellitus

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月24日

查看全文
  • Selim Aydemir,
  • Sidar Şiyar Aydın,
  • Onur Altınkaya,
  • Murat Özmen,
  • Nurullah Çomaklı,
  • Emrah Aksakal

摘要

Background

Predicting mortality and major adverse cardiovascular events (MACE) in Type 2 diabetes mellitus (T2DM) is important, but no routinely recommended risk score exists. The HANBAH Score is a recently established risk score for mortality prediction in acute heart failure. This study aimed to investigate the relationship between the HANBAH Score and mortality and MACE in T2DM patients.

Methods

This study was retrospective, and patients who applied to the outpatient clinic diagnosed with T2DM were included. The patients’ HANBAH Score was calculated. The relationship between the HANBAH score and mortality and MACE was examined.

Results

7611 T2DM patients were included in this study. The mean age of the patients was 59.1 ± 12.8 years, and 3187 (41.9%) were male. The mortality rate was 1% (76 patients), and the MACE rate was 5.8% (438 patients). The mean follow-up time was 604 days. HANBAH Score was an independent predictor of mortality (HR: 2.260, 95%CI:1.738–2.939, p < 0.001) and MACE (HR: 1.238, 95%CI:1.094-1.400, p < 0.001). ROC curve analysis showed that HANBAH Score highly predicted mortality (AUC: 0.846, 95%CI: 0.794–0.898, p < 0.001).

Conclusions

This study showed that the HANBAH Score is a predictor of MACE and mortality in patients with T2DM.